218 The Impact on Minimally Invasive Urological Cancer Surgery During the Covid-19 Pandemic
| Autor: | Steve Leung, C. Boyle, Alexander Laird, Kevin M Gallagher, Daniel W. Good, S. A. McNeill |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
2019-20 coronavirus outbreak
medicine.medical_specialty AcademicSubjects/MED00910 Coronavirus disease 2019 (COVID-19) Posters business.industry Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Pandemic Urological cancer Medicine Surgery AcademicSubjects/MED00010 business Intensive care medicine Trauma/Emergency General Surgery |
| Zdroj: | The British Journal of Surgery |
| ISSN: | 1365-2168 0007-1323 |
| Popis: | Aim Learned bodies recommended restricted use of, or extensive precautions when using, laparoscopic/robotic surgery during the Covid-19 pandemic. We aimed to determine whether minimally invasive surgery (MIS) in uro-oncology patients was safe for patients and staff. Method From 16 March to 16 June 2020, patients having MIS in a tertiary referral urology centre were identified from a prospectively collected database. Patient characteristics, operative details and 30-day follow-up for adverse events were recorded including Covid-19 tests and results. Any theatre staff Covid-19 event was traced back 14 days to determine any involvement in these cases. Results 87 patients were eligible for inclusion (33 robotic prostatectomies, 38 laparoscopic prostatectomies, 11 laparoscopic nephrectomies, 5 robotic nephrectomies). All patients were assessed for symptoms of Covid-19 on the day of theatre. 18(21%) patients had pre-operative screening (all swabs, no CT chest). 46(53%) underwent 14 days pre-operative self-isolation. 38(44%) cases were performed with FFP3 protection. No modification to operating procedure was made for any cases. No patients tested positive for Covid-19 in the 30-day postoperative period. No staff member involved tested positive in the postoperative period. 1 patient tested positive pre-operatively, delaying the operation by 7 weeks. No patients tested positive after the introduction of mandatory screening. Conclusions Based on our case-series MIS urological surgery appears to be safe for patients and staff, with no increased risk of Covid-19 complications in patients who are asymptomatic pre-operatively. The introduction of mandatory pre-operative swabs for elective patients, and the use of FFP3 protection, did not significantly alter results. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|